Psoriasis clinically presents with well-demarcated, scaly erythematous patches and plaques on the trunk and extremities, typically developing days to months after initiation of PD-1 inhibitors and has been seen in patients with and without a previous history of psoriasis (66). The gene discussed is PDCD1; the disease is psoriasis.